1-4 of 4
Arya Roy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia

Hassan Awada, Mina Abdelmalek, Tara L. Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark G. Faber, Arya Roy, Ashish Gupta, Matthew Gravina, Sheeba Ba Aqeel, Alankrita Taneja, Pamela J. Sung, Steven D. Green, Amanda Przespolewski, James E. Thompson, Elizabeth A. Griffiths, Eunice S. Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 135–136.
https://doi.org/10.1182/blood-2022-168482
Published: 2022
Journal Articles

Spectrum of Second Primary Malignancies in Angioimmunoblastic T-Cell Lymphoma

Richa Parikh, Arya Roy
Journal: Blood
Blood (2022) 140 (Supplement 1): 3692–3693.
https://doi.org/10.1182/blood-2022-171224
Published: 2022
Journal Articles

Clinical Impact of the Intensity of Induction Regimens Prior to Consolidation in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma (PTCL)

Muhammad Salman Faisal, Gabrielle Hartman, Arya Roy, Andrea Anampa-Guzman, Sheeba Ba Aqeel, Hassan Awada, Matthew J Cortese, Pallawi Torka, Suchitra Sundaram, Paola Ghione
Journal: Blood
Blood (2022) 140 (Supplement 1): 6573–6574.
https://doi.org/10.1182/blood-2022-169156
Published: 2022
Journal Articles

A Retrospective Study of Antibody Titers in Patients with Plasma Cell Disorders

Alankrita Taneja, Katy Wang, Sarah Parker, Sheeba Ba Aqeel, Joseph D. Tario, Jr., Hassan Awada, Arya Roy, Maximilian Merz, Philip L. McCarthy, Jens Hillengass
Journal: Blood
Blood (2022) 140 (Supplement 1): 10029–10030.
https://doi.org/10.1182/blood-2022-169163
Published: 2022